Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/transgenomic--inc--reports-third-quarter-2009-results-14739-5/;+health+history;+medical+history.html) was not found.

Search biology technology 1 transgenomic inc reports third quarter 2009 results 14739 5 ;+health+history;+medical+history html at Google

Search biology technology 1 transgenomic inc reports third quarter 2009 results 14739 5 ;+health+history;+medical+history html at Yahoo

Search biology technology 1 transgenomic inc reports third quarter 2009 results 14739 5 ;+health+history;+medical+history html at Msn

Google
 
(Date:11/24/2009)... has long held secrets of the earth,s history lock...s been very little information on the environments...llions of years. Now, a team of researchers from n...to the tune of $10 million dollars by the National...of things literally. These scientists will drill ...
(Date:11/24/2009)...e in Spanish . , The presence of increased ...ory substances in the blood, hinders the loss and ... project of the University of Navarra conducted by...ol of Pharmacy. , The project, entitled "A nutri...control of body weight and inflammation," examines...
(Date:11/23/2009)...ember 23, 2009 Applied mathematicians dissected t...lia ), a characteristic long leaf with a saddle-li... the edges. The simple cause of the lily,s fan-lik...uring differential growthwas revealed by using an ... , Haiyi Liang, a postdoctoral student at Harvar...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Messages Heard Better in the Right Ear 50163 1Messages Heard Better in the Right Ear 50163 2Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 1Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 2Bausch 26 Lomb Vision Care Strengthens Its Commitment to ReNu 28R 29 Brand and the Eye Care Community 50159 3Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 1Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 2Positive CHMP Opinion for JAVLOR 28R 29 in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum Containing Regimen 50155 3
(Date:11/27/2009)...Newswire/--Preventingdiseaseisthegoalofeveryhealth...beingaddedtoassistindiseaseprevention.Butdoallvacc...whenareadditional,boostershots,neededtokeepimmunit...ournaloftheAmericanAcademyofPediatrics,MichaelPich...itute,basedatRochesterGeneralHospitalinRochesterNY...
(Date:11/27/2009)...ewswire/--TeamGarmin-Slipstream,theeliteAmericanpr...developingthenextgenerationofcyclingchampions,anno...ththeadditionofTransitionsOpticalasanewsponsorofth...turerofadaptiveeyewear,offeringthemostadvancedphot...ensessuchasTransitionslensesaswellasTransitionsSOL...
(Date:11/27/2009)...ire-FirstCall/--ShamirOpticalIndustryLtd.(Nasdaq: ...ductsandtechnologytotheophthalmiclensmarket,announ...ddistributioninanaggregateamountofUS$10million(app...representativerateofexchange),orapproximatelyUS$0....presentativerateofexchange)perordinarysharebasedon...
(Date:11/27/2009)... has announced that it has become a national spons... nonprofit organizations dedicated to arthritis re... Delray Beach, FL (Vocus) November 27,...company specializing in the marketing and retail d...nnounced today that is has become a national spons...
(Date:11/27/2009)...les may reduce future disease burden, researchers ... -- Encouraging city dwellers to walk and bicycle ...lic health benefits than increased used of low-emi...The study compared the projected health effects in...s for London, England, and Delhi, India: business...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:More Foot Power, Less Car Pollution Best for Health 2
...96 x 0.2 ml reaction module is used for nucleic ac...d with an interchangeable 96-well reaction module ...h optical modules for real-time PCR and features t...ock, or in-sample probe. It includes the iCycler b...
... benchtop and stackable multi-function incubator. ...isplay screen to accurately control temperature an...y distribute temperature in the incubator. Tempera...sor controller. Built in maintenance-free stepping...
Rabbit Anti-Autotaxin / ENPP2 Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Mouse Anti-Human TNPO2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products:
... surgeon with an indirect illumination system that...zed through the laser microscope. Through use of t...surgeon can enhance visualization of interface deb... flap striae and flap alignment. Use of the Lumina...
...to satisfy the needs of the physician's office, ho...is supplied with the latest high performance PC an...rts, cabinets and monitor sizes to suit your indiv...ms consist of the high response 50-channel AS40 Am...
... Beehive product line, combines decades of experie...the 21st century. Beehive Millennium is a powerful...ding complete data acquisition, recording and revi...monitoring applications. Beehive Millennium featur...
...joint, and flexible wire with carbon tip. Compos...le support for ball joint of electrodes. Conexion ...odes with flexible wire and carbon tip. Referenc...g post. Key to screw mounting post in the skull....
Medicine Products:
(Date:11/27/2009)...DURHAM,N.C.,Nov.27/PRNewswire/--CromozInc.,located...rbonnanotube-basedcancerdrugdeliverysysteminHydera...efunctionalgroupsonthewallsthatallowsforconjugatio...ndianInstituteofKanpur(ITT).Theconjugatedcarbonnan...targetthecancersitewhichhasthepotentialtoincreaset...
(Date:11/27/2009)...PARIS,November27/PRNewswire-FirstCall/--Stallergen...)inbothadultsandchildren,throughaMutualRecognition...asbeenmarketed,wasthereferenceMemberstate. , ...a,Cyprus,the,CzechRepublic,Estonia,France,Germany,...embourg,Malta,theNetherlands,Poland,Portugal,Roma...
(Date:11/27/2009)... A mechanised blue dye test alte...ackaging quality assurance one step closer for pha...t leak testing machine developed by Sepha for ...talled in several local and global pharma-companie...ss quality assurance and productivity improvements...
(Date:11/26/2009)...ST LAFAYETTE, Ind. - A new generation of ultrasmal...ng tiny structures called semiconducting nanowires...searchers at IBM, Purdue University and the Univer...hers have learned how to create nanowires with lay...d at the atomic level, which is a critical require...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
(Date:11/25/2009)...swire/--RemediumTechnologiesInc.,acompanydevelopin...firstprizeand$10,000intheMostPromisingSecurityIdea...ficialsannouncetoday. ,, Selectedfrommorethan10...eirinventionattheGSCSecuritySummitconferenceheldat...ediumtechnologies.com )isdevelopingahigh-pressuref...
(Date:11/25/2009)...stCall/--ChinaSkyOne,Medical,Inc.("ChinaSkyOneMedi...ntegratedpharmaceuticalcompanydevelopingandproduci...na("PRC"),today,announcedthattheCompanyrecentlypas...maceuticalandBiologicalProducts("ICPBP")examinatio...rostateSpecific,Antigen(ColloidalGold)anditsDeterm...
(Date:11/25/2009)...tCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalproduct...tems,announcedtodaythatClintSeverson,chairmanandch...rJaffrayHealthCareConferenceonWednesday,December2,...rkPalaceHotelinNewYorkCity. ,, AboutAbaxis ,...loodanalysissystemsforuseinanyveterinaryorhumanpat...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3RainEarth Obtains Patent Approvals for Its Core Technology 50153 1RainEarth Obtains Patent Approvals for Its Core Technology 50153 2RainEarth Obtains Patent Approvals for Its Core Technology 50153 3Sentry Data Systems Announces Claims Guardian 28TM 29 50150 1Sentry Data Systems Announces Claims Guardian 28TM 29 50150 2Sentry Data Systems Announces Claims Guardian 28TM 29 50150 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5